Welcome to the Definitive Forum Uniting Industry & Academia to Spearhead Innate Immunity Development
Join industry trailblazers at the 10th Annual Innate Killer Summit as they reveal long-anticipated clinical data, critical advancements in cryopreservation, novel NK engagers and more!
Get involved in this unmissable summit to learn and connect with pioneers including Artiva Bio, Indapta Therapeutics, Genentech, Immunity Bio and Takeda, as they pick up pace to develop life-changing off-the-shelf therapies for cancer, autoimmune disease, and infectious disease.
TAKE A LOOK AT THE BRAND-NEW AGENDA FOR 2025!
Attend the 10th Annual Innate Killer Summit to:
Explore the applications of NK biology to autoimmune disease by understanding preliminary safety and mechanisms with Artiva Bio and Century Therapeutics
Dive into NK engineering with insights from the latest advances, including innovative CAR designs and gene editing techniques with Katy Rezvani’s Lab and NKILT Therapeutics
Leverage combination approaches to enhance persistence, proliferation and potency of NK cells with Genentech and Indaptus Therapeutics
Review case studies that showcase the real-life applications and impact of NK cell therapies, with detailed presentations from NKore Biotherapeutics and INmune Bio
Discover the versatility of NK cells and how they can be leveraged to expand into indications such as HIV and hepatitis B with Immunity Bio and the University College London
Who Will You Meet?
Connect with top NK pioneers across cell therapy, engager, TCR and cytokine approaches all in one room to open doors for partnerships in combination therapies and cross-functional learning as this tight knit community comes together to advance innate immunity-based therapies.
What Do The NK Community Have To Say?
"The best researchers from the field, the quality of the presentations, enough time for networking, talking to the companies presenting new tech, and to rest between sessions”
Senior Group Leader, Zelluna Immunotherapy
"Exchange, debate and discuss novel approaches and how we can improve our technologies to get faster and more efficiently to patients”
President, Chief Executive Officer & Co-Founder, NKILT Therapeutics